How to break into Biotech/therapeutics HFs

Hi everyone, I recently graduated with a PhD and is looking to break into hedge funds. Wondering how someone can break into this space with limited public market experience. I do have my own pitches/differentiated views and always attach them on applications but rustier on the modeling since I do not come from finance. Love to chat with someone or get tips on how to succeed!! 

4 Comments
 

Breaking into biotech/therapeutics hedge funds with a PhD but limited public market experience is challenging but definitely achievable. Based on the most helpful WSO content, here are some actionable tips:

1. Leverage Your PhD Expertise

  • Your PhD gives you a significant edge in understanding the science behind biotech/therapeutics. Hedge funds value this expertise, especially for evaluating technical risks in early-stage companies.
  • Highlight your ability to quickly digest and analyze scientific papers, clinical data, and regulatory documents. This is a key skill for biotech investing.

2. Develop Financial and Modeling Skills

  • While your scientific background is a strength, hedge funds will expect you to have a baseline understanding of financial modeling and valuation techniques.
  • Start by learning the basics of financial statement modeling, DCF, and biopharma-specific valuation methodologies. You can use resources like SEC filings, investor presentations, and equity research models to practice.
  • Focus on scenario-based forecasting, which is crucial for biopharma valuation. Understanding how to model technical risks and probabilities of success for drugs at different stages (e.g., preclinical, Phase 1) is particularly important.

3. Build and Showcase Your Investment Pitches

  • Continue refining your pitches and differentiated views. Tailor them to demonstrate your understanding of both the science and the market dynamics.
  • Include detailed diligence in your pitches, such as clinical trial data analysis, market adoption probabilities, and competitive landscape assessments.

4. Network Strategically

  • Networking is critical for breaking into hedge funds. Reach out to professionals in the space, especially those with similar backgrounds (e.g., PhDs who transitioned into finance).
  • Use platforms like LinkedIn and attend industry events to connect with biotech investors. Headhunters can also be a valuable resource for finding opportunities.

5. Target the Right Funds

  • Focus on funds that value scientific expertise, such as those specializing in biotech or healthcare. Many of these funds hire PhDs for their technical knowledge.
  • Early-stage VC funds and hedge funds with a strong biotech focus are good starting points. Keep in mind that some funds may prioritize candidates with prior finance experience, so be prepared to demonstrate your ability to bridge the gap.

6. Be Persistent and Open to Learning

  • Breaking into this space may take time, especially without prior public market experience. Be persistent and open to feedback.
  • Consider roles that allow you to build relevant experience, such as healthcare equity research or consulting, as stepping stones to hedge funds.

By combining your scientific expertise with a solid foundation in finance and networking effectively, you can position yourself as a strong candidate for biotech/therapeutics hedge funds.

Sources: How to be a Millionaire Trader, Biotech finance part 2: valuation methodologies and modeling considerations, Biotech finance: from IB to VC / HF to funded startup

I'm an AI bot trained on the most helpful WSO content across 17+ years.
 

Yes, 100%. Look at ER in those places first, banks take on a lot of PhD people who can review drug research and have deeper insight. Usually straight to hedge fund is harder because they don't have the same training infrastructure for someone completely unfamiliar with markets. It does happen, but usually only at the more quant-y firms with bigger classes. 

 
Most Helpful

Est ipsum qui ducimus. Id eum aut velit perferendis nulla. Commodi dolores ab vel voluptas consequatur.

Quo deleniti ut ducimus. Debitis nisi sit ab minima repellendus facere.

Reiciendis eum architecto consequatur laboriosam omnis. Beatae id ab suscipit reiciendis. Nostrum itaque cumque harum enim dolor.

Rerum itaque est iure quo sequi. Non sunt deserunt dolorem. Ratione id similique et qui neque iste distinctio aliquam. Aspernatur sequi sed quod a a fugiat nisi.

Career Advancement Opportunities

July 2026 Hedge Fund

  • Point72 99.0%
  • D.E. Shaw 98.1%
  • Citadel Investment Group 97.1%
  • AQR Capital Management 96.2%
  • Magnetar Capital 95.2%

Overall Employee Satisfaction

July 2026 Hedge Fund

  • Magnetar Capital 99.0%
  • D.E. Shaw 98.0%
  • Blackstone Group 97.1%
  • Citadel Investment Group 96.1%
  • Millennium Partners 95.1%

Professional Growth Opportunities

July 2026 Hedge Fund

  • AQR Capital Management 99.0%
  • Point72 98.1%
  • D.E. Shaw 97.1%
  • Citadel Investment Group 96.2%
  • Magnetar Capital 95.2%

Total Avg Compensation

July 2026 Hedge Fund

  • Portfolio Manager (9) $1,648
  • Vice President (27) $464
  • Director/MD (12) $423
  • NA (9) $320
  • Engineer/Quant (86) $288
  • 3rd+ Year Associate (26) $284
  • Manager (4) $282
  • 2nd Year Associate (32) $253
  • 1st Year Associate (77) $191
  • Analysts (242) $181
  • Intern/Summer Associate (29) $145
  • Junior Trader (5) $102
  • Intern/Summer Analyst (282) $96
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”